Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$4.58 - $9.21 $35,504 - $71,395
-7,752 Reduced 17.34%
36,950 $256,000
Q2 2022

Aug 04, 2022

SELL
$7.06 - $23.63 $6,523 - $21,834
-924 Reduced 2.03%
44,702 $374,000
Q1 2022

May 13, 2022

BUY
$21.6 - $27.79 $20,973 - $26,984
971 Added 2.17%
45,626 $1.04 Million
Q4 2021

Feb 10, 2022

SELL
$23.0 - $29.01 $192,510 - $242,813
-8,370 Reduced 15.79%
44,655 $1.23 Million
Q3 2021

Nov 12, 2021

SELL
$25.04 - $30.06 $118,739 - $142,544
-4,742 Reduced 8.21%
53,025 $1.47 Million
Q2 2021

Aug 10, 2021

SELL
$27.43 - $32.7 $86,953 - $103,659
-3,170 Reduced 5.2%
57,767 $1.7 Million
Q1 2021

May 13, 2021

SELL
$21.37 - $34.38 $36,713 - $59,064
-1,718 Reduced 2.74%
60,937 $1.93 Million
Q4 2020

Feb 10, 2021

SELL
$15.31 - $21.12 $3,551 - $4,899
-232 Reduced 0.37%
62,655 $1.3 Million
Q3 2020

Nov 12, 2020

SELL
$14.88 - $20.13 $60,799 - $82,251
-4,086 Reduced 6.1%
62,887 $974,000
Q2 2020

Aug 13, 2020

SELL
$13.31 - $20.51 $188,482 - $290,442
-14,161 Reduced 17.45%
66,973 $1.22 Million
Q1 2020

May 14, 2020

SELL
$12.98 - $30.25 $20,806 - $48,490
-1,603 Reduced 1.94%
81,134 $1.25 Million
Q4 2019

Feb 10, 2020

SELL
$18.89 - $31.89 $93,826 - $158,397
-4,967 Reduced 5.66%
82,737 $2.47 Million
Q3 2019

Nov 12, 2019

SELL
$20.88 - $25.66 $838,102 - $1.03 Million
-40,139 Reduced 31.4%
87,704 $1.91 Million
Q2 2019

Jul 30, 2019

SELL
$20.52 - $26.45 $2.57 Million - $3.31 Million
-125,057 Reduced 49.45%
127,843 $3.23 Million
Q1 2019

May 14, 2019

SELL
$20.23 - $26.29 $122,108 - $158,686
-6,036 Reduced 2.33%
252,900 $6.22 Million
Q4 2018

Feb 12, 2019

BUY
$17.64 - $28.32 $1.65 Million - $2.64 Million
93,255 Added 56.29%
258,936 $4.8 Million
Q3 2018

Nov 13, 2018

BUY
$20.64 - $25.67 $3.42 Million - $4.25 Million
165,681 New
165,681 $4.23 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.